Methylprednisolone Withdrawn Phase N/A Trials for Lung Cancers Diagnostic

IndicationsStatusPurposePhase
WithdrawnDiagnosticNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01789892Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer